Integrated Advisors Network’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-29,726
Closed -$1.52M – 720
2022
Q1
$1.52M Sell
29,726
-26,238
-47% -$1.26M 0.09% 236
2021
Q4
$3.13M Buy
55,964
+136
+0.2% +$6.89K 0.18% 140
2021
Q3
$2.65M Buy
55,828
+7,510
+16% +$383K 0.18% 149
2021
Q2
$2.25M Buy
48,318
+30,544
+172% +$1.34M 0.17% 152
2021
Q1
$709K Buy
+17,774
New +$702K 0.06% 260

Other funds holding RXL

Integrated Advisors Network's RXL Position: Q2 2022 in Review

Integrated Advisors Network sold out of ProShares Ultra Health Care (RXL) in Q2 2022, closing a stake of 29,726 shares — an estimated $1.52M sold.

Integrated Advisors Network first reported a position in RXL in Q1 2021 and held it in 5 quarters. The position peaked at $3.13M in Q4 2021. 24 funds tracked by Wall St. Rank hold RXL as of Q2 2022.

  • Integrated Advisors Network reported no remaining ProShares Ultra Health Care position as of Q2 2022 after selling out during the quarter.
  • Integrated Advisors Network sold 29,726 ProShares Ultra Health Care shares in Q2 2022, an estimated $1.52M.
  • Integrated Advisors Network first reported a position in ProShares Ultra Health Care in Q1 2021 and held it in 5 quarters.
  • Integrated Advisors Network's ProShares Ultra Health Care position peaked at $3.13M in Q4 2021.
  • 24 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q2 2022.

Based on Integrated Advisors Network's 13F filing for Q2 2022, filed 12 Aug 2022.